Skip to content

Evaluation of the rasayana effect of Amrit Bhallataka and Ashwagandhadi lehya in akaalaja jara (Premature ageing)

A randomised comparative clinical trial to evaluate the rasayana effect of Amrit Bhallataka and Ashwagandhadi lehya in akaalaja jara (Premature ageing)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048302
Enrollment
60
Registered
2022-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E46- Unspecified protein-calorie malnutrition

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.having 3 symptoms of premature ageing 2.Patients willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with any type of psychiatric disorder, Alzheimerâ??s disease, parkinsonism etc. 2.Patients with any major diseases like carcinoma, heart disease, DM, hyperhypothyrodism, hypertension etc. ï?? Patients giving present history of addiction to drug, tobacco or alcohol. ï?? Pitta prakriti person will be excluded on the basis of CCRAS short prakriti performa ï?? Pregnant and lactating females

Design outcomes

Primary

MeasureTime frame
Change in score of Akaalaj jara lakshana Timepoint: 7 weeks

Secondary

MeasureTime frame
change in WHO-Quality of Life Bref Oxidative stress- SOD level Hb LFT Timepoint: 48 days

Countries

India

Contacts

Public ContactDr Jyoti Rani

National Institute of Ayurveda

anita31sharma@yahoo.com9414078653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026